At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 564 enrolled
Drug / intervention
Valsartan/Amlodipine +1 moredrug
Likely dose
Valsartan/Amlodipine 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 12 Weeks, Multi-center, Open Label, Randomized, Active Drug Parallel Control Trial to Compare the Effectiveness of Valsartan/Amlodipine and Nifedipine in Treating Chinese Hypertensive Patients Not Respond to Mono Antihypertensive Treatment
In Brief
A Phase 4 clinical trial evaluating Valsartan/Amlodipine and Nifedipine for Hypertension. Completed, enrolled 564 participants across 1 site.
Detailed Summary
The purpose of this study was to compare the efficacy and safety of Valsartan/Amlodipine (EXforge®) with nifedipine, as well as vascular function index.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesChina
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedJul 2010
Primary CompletionApr 2011
TodayJul 2026
First PostedJul 22, 2010
Enrollment StartMay 1, 2010
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 15.9 years ago
Interventions
Valsartan/Amlodipinedrug
Valsartan/Amlodipine 80/5mg single pill combination (SPC)
Nifedipinedrug
Nifedipine GITS (Gastro-Intestinal Therapeutic System ) 30 mg